1610420-28-4
1610420-28-4
Chemical Structure
(Rac)-Zevaquenabant
Synonym(s): (Rac)-MRI-1867
- CAS No.: 1610420-28-4
- Formula:C25H21ClF3N5O2S
- Molecular Weight:547.98
IUPAC Name: (Z)-N-((Z)-1-aminoethylidene)-3-(4-chlorophenyl)-4-phenyl-N'-((4-(trifluoromethyl)phenyl)sulfonyl)-4,5-dihydro-1H-pyrazole-1-carboximidamide
InChIKey: NLXIJZHFEOSWPU-UHFFFAOYSA-N
SMILES: O=S(/N=C(N1N=C(C2=CC=C(Cl)C=C2)C(C3=CC=CC=C3)C1)/N=C(N)/C)(C4=CC=C(C(F)(F)F)C=C4)=O
Biological Activity: (Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-Zevaquenabant | 99.20% | (Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
